Back
AbbVie, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
59
ABBV
AbbVie, Inc.
Last Price:
$228.65
Seasonality Move:
5.64%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.
AbbVie, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 229.08 | Buy |
| 20-day SMA: | 227.98 | Buy |
| 50-day SMA: | 227.78 | Buy |
| 200-day SMA: | 204.19 | Buy |
| 8-day EMA: | 228.35 | Buy |
| 20-day EMA: | 228.17 | Buy |
| 50-day EMA: | 225.02 | Buy |
| 200-day EMA: | 207.27 | Buy |
AbbVie, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 53.38 | Buy |
| Chaikin Money Flow: | 4018305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.73 - 232.97) | Buy |
| Bollinger Bands (100): | (200.98 - 230.84) | Buy |
AbbVie, Inc. Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for AbbVie, Inc. Stock
Is AbbVie, Inc. Stock a Buy?
-
AbbVie, Inc. share price is 230.24 while ABBV 8-day simple moving average is 229.08, which is a Buy signal.
-
The stock price of ABBV is 230.24 while AbbVie, Inc. 20-day SMA is 227.98, which makes it a Buy.
-
AbbVie, Inc. 50-day simple moving average is 227.78 while ABBV share price is 230.24, making it a Buy technically.
-
ABBV stock price is 230.24 and AbbVie, Inc. 200-day simple moving average is 204.19, creating a Buy signal.
ABBV Technical Analysis vs Fundamental Analysis
Buy
59
AbbVie, Inc. (ABBV)
is a Buy
Is AbbVie, Inc. a Buy or a Sell?
-
AbbVie, Inc. stock is rated a BuyThe current AbbVie, Inc. [ABBV] share price is $230.24. The Score for ABBV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
AbbVie, Inc. Stock Info
Market Cap:
406.9B
Price in USD:
230.24
Share Volume:
4.9M
AbbVie, Inc. 52-Week Range
52-Week High:
244.81
52-Week Low:
164.39
Buy
59
AbbVie, Inc. (ABBV)
is a Buy
AbbVie, Inc. Share Price Forecast
-
What is the AbbVie, Inc. stock price today?The AbbVie, Inc. stock price is 230.24 USD today.
-
Will ABBV stock go up or go down?AbbVie, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is AbbVie, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie, Inc. is not overvalued.
Is AbbVie, Inc. Stock a Buy?
-
AbbVie, Inc. share price is 230.24 while ABBV 8-day exponential moving average is 228.35, which is a Buy signal.
-
The stock price of ABBV is 230.24 while AbbVie, Inc. 20-day EMA is 228.17, which makes it a Buy.
-
AbbVie, Inc. 50-day exponential moving average is 225.02 while ABBV share price is 230.24, making it a Buy technically.
-
ABBV stock price is 230.24 and AbbVie, Inc. 200-day simple moving average is 207.27, creating a Buy signal.
Fundamental Analysis of AbbVie, Inc.
Is AbbVie, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $3.61 per share.
Technical Analysis of AbbVie, Inc.
Should I short AbbVie, Inc. stock?
-
ABBV Moving Average Covergence Divergence (MACD) indicator is 0.72, suggesting AbbVie, Inc. is a Buy
-
AbbVie, Inc. Relative Strength Index (RSI) is 53.38, which suggest AbbVie, Inc. is overbought
-
The Bollinger Bands (25) for AbbVie, Inc. is (219.73 - 232.97), which suggest AbbVie, Inc. is a Buy
-
The Bollinger Bands (100) for AbbVie, Inc. is (200.98 - 230.84), which suggest AbbVie, Inc. is a Buy
* AbbVie, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.